(Q83263799)
Statements
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy (English)
Eric Lawitz
Eliot Godofsky
Thomas Marbury
Tuan Nguyen
June Ke
MeiMei Huang
Jens Praestgaard
Denise Serra
Thomas G Evans
19 January 2011